scispace - formally typeset
D

Deborah J. Cook

Researcher at McMaster University

Publications -  942
Citations -  165225

Deborah J. Cook is an academic researcher from McMaster University. The author has contributed to research in topics: Intensive care & Randomized controlled trial. The author has an hindex of 173, co-authored 907 publications receiving 148928 citations. Previous affiliations of Deborah J. Cook include McMaster University Medical Centre & Queen's University.

Papers
More filters
Journal ArticleDOI

Cost-effectiveness of dalteparin vs unfractionated heparin for the prevention of venous thromboembolism in critically ill patients

TL;DR: From a health care payer perspective, the use of the LMWH dalteparin for VTE prophylaxis among critically ill medical-surgical patients was more effective and had similar or lower costs than the use for UFH, consistent among higher- and lower-spending health care systems.
Journal ArticleDOI

Experiences and Expressions of Spirituality at the End of Life in the Intensive Care Unit

TL;DR: The Three Wishes Project invites and supports the expression of myriad forms of spirituality during the dying process in the ICU, and family members and clinicians consider spirituality an important dimension of end‐of‐life care.
Journal ArticleDOI

Most critically ill patients are perceived to die in comfort during withdrawal of life support: a Canadian multicentre study.

TL;DR: Most patients were perceived by family members to die in comfort during a withdrawal of LS, and perceptions of patient comfort and drug use in the hours before death were not associated with the mode or sequence of withdrawal ofLS, or the time to death.
Journal ArticleDOI

Prevention of Venous Thromboembolism in Critically Ill Medical Patients: A Franco-Canadian Cross-sectional Study

TL;DR: In this binational cross-sectional observational study of medical ICU patients, it was found that 92% of eligible patients received either UFH or LWMH for VTE prophylaxis, and differences in prescribing between countries include significantly greater use of LMWH in France, but use of lower doses than in Canada, and greater use in Canada.
Journal ArticleDOI

Trials of Corticosteroids to Prevent Postextubation Airway Complications

TL;DR: Overall, it is found that corticosteroids decreased the risk of postextubation stridor in children by about 40%, however, the effect of cortICosteroids in children and adults to reduce postextUBation complications such as reintubation is uncertain.